If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020
2019

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., Dec 2019, In : Gynecologic Oncology. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial: Gynecologic Oncology

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., 2019, In : Gynecol. Oncol.. 155, 3, p. 406-412 7 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., Jul 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

MITO Investigators, Jun 2019, In : Gynecologic Oncology. 153, 3, p. 535-540 6 p.

Research output: Contribution to journalArticle

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

Pignata, S., Scambia, G., Lorusso, D., De Giorgi, U., Nicoletto, M. O., Lauria, R., Mosconi, A. M., Sacco, C., Omarini, C., Tagliaferri, P., Ferrandina, G., Cinieri, S., Savarese, A., Valabrega, G., Pisano, C., Salutari, V., Raspagliesi, F., Kopf, B., Cecere, S. C., Amadio, G. & 11 others, Maltese, G., Di Napoli, M., Greggi, S., Signoriello, S., Daniele, G., Sacco, A., Losito, S., Normanno, N., Perrone, F., Gallo, C. & Piccirillo, M. C., 2019, In : Gynecologic Oncology. 153, 3, p. 535-540 6 p.

Research output: Contribution to journalArticle

2018

Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

Mangili, G., Cioffi, R., Danese, S., Frigerio, L., Ferrandina, G., Cormio, G., Rabaiotti, E., Scarfone, G., Gadducci, A., Bergamini, A., Pisano, C. & Candiani, M., 2018, In : Gynecologic Oncology. 151, 3, p. 449-452 4 p.

Research output: Contribution to journalArticle

Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study

Mangili, G., Cioffi, R., Danese, S., Frigerio, L., Ferrandina, G., Cormio, G., Rabaiotti, E., Scarfone, G., Gadducci, A., Bergamini, A. & Pisano, C., 2018, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Obesity and cancer: biological links and treatment implications

Ottaiano, A., De Divitiis, C., Capozzi, M., Avallone, A., Pisano, C., Pignata, S. & Tafuto, S., 2018, In : Current Cancer Drug Targets.

Research output: Contribution to journalArticle

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

Piccirillo, M. C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S. & Perrone, F., May 1 2018, In : Annals of Oncology. 29, 5, p. 1189-1194 6 p.

Research output: Contribution to journalArticle

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinumbased chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

Piccirillo, M. C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S. & Perrone, F., 2018, In : Annals of Oncology. 29, 5, p. 1189-1194 6 p.

Research output: Contribution to journalArticle

Trabectedin in Ovarian Cancer: Is it now a Standard of Care?

Ventriglia, J., Paciolla, I., Cecere, S. C., Pisano, C., Di Napoli, M., Arenare, L., Setola, S. V., Losito, N. S., Califano, D., Orditura, M. & Pignata, S., 2018, In : Clinical Oncology.

Research output: Contribution to journalArticle

2017

Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin

Bergamini, A., Pisano, C., Di Napoli, M., Arenare, L., Della Pepa, C., Tambaro, R., Facchini, G., Gargiulo, P., Rossetti, S., Mangili, G., Pignata, S. & Cecere, S. C., Jan 1 2017, In : Gynecologic Oncology. 144, 1, p. 72-76 5 p.

Research output: Contribution to journalArticle

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer

Pignata, S., Scambia, G., Bologna, A., Signoriello, S., Vergote, I. B., Wagner, U., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Piccirillo, M. C., Gallo, C. & Perrone, F., Oct 2017, In : Journal of Clinical Oncology. p. JCO2017734293

Research output: Contribution to journalArticle

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

Pignata, S., Scambia, G., Bologna, A., Signoriello, S., Vergote, I. B., Wagner, U., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Piccirillo, M. C., Gallo, C. & Perrone, F., Oct 2017, In : Journal of Clinical Oncology. p. JCO2017734293

Research output: Contribution to journalArticle

Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study

Pignata, S., Scambia, G., Bologna, A., Signoriello, S., Vergote, I. B., Wagner, U., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Piccirillo, M. C., Gallo, C. & Perrone, F., 2017, In : Journal of Clinical Oncology. 35, 29, p. 3347-3353 7 p.

Research output: Contribution to journalArticle

Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study

Pignata, S., Scambia, G., Bologna, A., Signoriello, S., Vergote, IB., Wagner, U., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, SC., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Piccirillo, MC., Gallo, C. & Perrone, F., 2017, In : Journal of Clinical Oncology. 35, 29, p. 3347-3353 7 p.

Research output: Contribution to journalArticle

Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study

Pignata, S., Scambia, G., Bologna, A., Signoriello, S., Vergote, I. B., Wagner, U., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S. C., Di Napoli, M., Salutari, V. & 8 others, Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Piccirillo, M. C., Gallo, C. & Perrone, F., 2017, In : Journal of Clinical Oncology. 35, 29, p. 3347-3353 7 p.

Research output: Contribution to journalArticle

2016

Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer

Gargiulo, P., Arenare, L., Pisano, C., Cecere, S. C., Falivene, S., Greggi, S., Tambaro, R., Facchini, G., De Palma, G., Pepa, C. D., Pignata, S. & Di Napoli, M., Jan 1 2016, In : Oncology. 90, 1, p. 29-35 7 p.

Research output: Contribution to journalArticle

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial

Scambia, G., Pignata, S., Amadio, G., Lepori, S., Mosconi, A. M., Pisano, C., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V. & Ferrandina, G., Mar 1 2016, In : Annals of Oncology. 27, 3, p. 487-493 7 p., mdv608.

Research output: Contribution to journalArticle

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial

Lorusso, D., Scambia, G., Pignata, S., Sorio, R., Amadio, G., Lepori, S., Mosconi, A., Pisano, C., Mangili, G., Maltese, G., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V., Raspagliesi, F. & Ferrandina, G., Mar 1 2016, In : Annals of Oncology. 27, 3, p. 487-493 7 p., mdv608.

Research output: Contribution to journalArticle

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial

Lorusso, D., Scambia, G., Pignata, S., Sorio, R., Amadio, G., Lepori, S., Mosconi, A. M., Pisano, C., Mangili, G., Maltese, G., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V., Raspagliesi, F. & Ferrandina, G., Mar 1 2016, In : Annals of Oncology. 27, 3, p. 487-493 7 p., mdv608.

Research output: Contribution to journalArticle

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial

Lorusso, D., Scambia, G., Pignata, S., Sorio, R., Amadio, G., Lepori, S., Mosconi, A. M., Pisano, C., Mangili, G., Maltese, G., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V., Raspagliesi, F. & Ferrandina, G., Mar 1 2016, In : Annals of Oncology. 27, 3, p. 487-493 7 p., mdv608.

Research output: Contribution to journalArticle

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial

Lorusso, D., Scambia, G., Pignata, S., Sorio, R., Amadio, G., Lepori, S., Mosconi, A. M., Pisano, C., Mangili, G., Maltese, G., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V., Raspagliesi, F. & Ferrandina, G., Mar 1 2016, In : Annals of Oncology. 27, 3, p. 487-493 7 p., mdv608.

Research output: Contribution to journalArticle

2015

A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: A multicentric Italian experience

Martella, F., Salutari, V., Marchetti, C., Pisano, C., Di Napoli, M., Pietta, F., Centineo, D., Caringella, A. M., Musella, A. & Fioretto, L., Sep 7 2015, In : Anti-Cancer Drugs. 26, 9, p. 990-994 5 p.

Research output: Contribution to journalArticle

Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer

Galdiero, F., Romano, A., Pasquinelli, R., Pignata, S., Greggi, S., Vuttariello, E., Bello, A. M., Calise, C., Scaffa, C., Pisano, C., Losito, N. S., Fusco, A., Califano, D. & Chiappetta, G., 2015, In : Oncotarget. 6, 22, p. 19328-19335 8 p.

Research output: Contribution to journalArticle

Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy

Della Pepa, C., Tonini, G., Santini, D., Losito, S., Pisano, C., Di Napoli, M., Cecere, S. C., Gargiulo, P. & Pignata, S., Feb 1 2015, In : Cancer Treatment Reviews. 41, 2, p. 136-143 8 p.

Research output: Contribution to journalArticle

Ovarian cancer standard of care: Are there real alternatives?

Pepa, C. D., Tonini, G., Pisano, C., Di Napoli, M., Cecere, S. C., Tambaro, R., Facchini, G. & Pignata, S., 2015, In : Chinese Journal of Cancer. 34, 1, p. 17-27 11 p.

Research output: Contribution to journalArticle

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): A randomised, open-label, phase 2 trial

Pignata, S., Lorusso, D., Scambia, G., Sambataro, D., Tamberi, S., Cinieri, S., Mosconi, A. M., Orditura, M., Brandes, A. A., Arcangeli, V., Panici, P. B., Pisano, C., Cecere, S. C., Di Napoli, M., Raspagliesi, F., Maltese, G., Salutari, V., Ricci, C., Daniele, G., Piccirillo, M. C. & 3 others, Di Maio, M., Gallo, C. & Perrone, F., 2015, In : The Lancet Oncology. 16, 5, p. 561-568 8 p.

Research output: Contribution to journalArticle

Progression-free survival by local investigator versus independent central review: Comparative analysis of the AGO-OVAR16 Trial

Floquet, A., Vergote, I., Colombo, N., Fiane, B., Monk, B. J., Reinthaller, A., Calvert, P., Herzog, T. J., Meier, W., Kim, J. W., Campo, J. M. D., Friedlander, M., Pisano, C., Isonishin, S., Crescenzo, R. J., Barrett, C., Wang, K., Mitrica, I. & Bois, A. D., 2015, In : Gynecologic Oncology. 136, 1, p. 37-42 6 p.

Research output: Contribution to journalArticle

2014

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): A randomised, multicentre, open-label, phase 3 trial

Pignata, S., Scambia, G., Katsaros, D., Gallo, C., Pujade-Lauraine, E., De Placido, S., Bologna, A., Weber, B., Raspagliesi, F., Panici, P. B., Cormio, G., Sorio, R., Cavazzini, M. G., Ferrandina, G., Breda, E., Murgia, V., Sacco, C., Cinieri, S., Salutari, V., Ricci, C. & 10 others, Pisano, C., Greggi, S., Lauria, R., Lorusso, D., Marchetti, C., Selvaggi, L., Signoriello, S., Piccirillo, M. C., Di Maio, M. & Perrone, F., 2014, In : The Lancet Oncology. 15, 4, p. 396-405 10 p.

Research output: Contribution to journalArticle

Second-line chemotherapy in recurrent clear cell ovarian cancer: Results from the Multicenter Italian Trials in Ovarian cancer (MITO-9)

Esposito, F., Cecere, S. C., Magazzino, F., Katsaros, D., Ottaiano, A., Gadducci, A., Pisano, C., Scalone, S., Rabaiotti, E., Salutari, V., Cormio, G., Canuto, E. M., Greggi, S., Savarese, A., Marinaccio, M., Scollo, P., Santeufemia, D. A., Sacco, C., Facchini, G. & Pignata, S., 2014, In : Oncology. 86, 5-6, p. 351-358 8 p.

Research output: Contribution to journalArticle

2013

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

Lee, C. K., Simes, R. J., Brown, C., Gebski, V., Pfisterer, J., Swart, A. M., Berton-Rigaud, D., Plante, M., Skeie-Jensen, T., Vergote, I., Schauer, C., Pisano, C., Parma, G., Baumann, K., Ledermann, J. A., Pujade-Lauraine, E., Bentley, J., Kristensen, G., Belau, A., Nankivell, M. & 4 others, Canzler, U., Lord, S. J., Kurzeder, C. & Friedlander, M., Apr 2013, In : Annals of Oncology. 24, 4, p. 937-943 7 p., mds538.

Research output: Contribution to journalArticle

Intravesical chemo-immunotherapy in non muscle invasive bladder cancer

Leopardo, D., Cecere, S. C., Napoli, M. D., Cavaliere, C., Pisano, C., Striano, S., Marra, L., Menna, L., Claudio, L., Perdonà, S., Setola, S., Berretta, M., Franco, R., Tambaro, R., Pignata, S. & Facchini, G., 2013, In : European Review for Medical and Pharmacological Sciences. 17, 16, p. 2145-2158 14 p.

Research output: Contribution to journalArticle

Multidisciplinary treatment of early stage endometrial cancer

Cecere, S. C., Pisano, C., Bamias, A., Di Napoli, M., Rossetti, S., Facchini, G., Tambaro, R. & Pignata, S., 2013, In : Anti-Cancer Agents in Medicinal Chemistry. 13, 6, p. 861-871 11 p.

Research output: Contribution to journalArticle

Testicular and testicular adnexa tumors in the elderly

Gigantino, V., La Mantia, E., Franco, R., Cecere, S., Rossetti, S., Di Napoli, M., Pisano, C., Berretta, M., Galzerano, A., Botti, G., Pignata, S. & Facchini, G., Mar 2013, In : Anti-Cancer Drugs. 24, 3, p. 228-236 9 p.

Research output: Contribution to journalArticle

The Pan European Emesis Registry (PEER): A critical appraisal of the Italian experience

Pastorelli, D., Locatelli, M. A., Melotti, B., Pisano, C., Turano, S., Mellino, U., Provinciali, N., Marchetti, P., Dazzi, C., Berretta, M., Giordano, A. & Lorusso, V., Oct 2013, In : Journal of Chemotherapy. 25, 5, p. 309-317 9 p.

Research output: Contribution to journalArticle

2012

(Anticancer Research 32, 5 (1889))

Cecere, S. C., Cannella, L., Rossetti, S., Di Napoli, M., Pisano, C., Fiore, F., Striano, S., Marra, L., Pignata, S. & Facchini, G., Dec 2012, In : Anticancer Research. 32, 12, p. 5734 1 p.

Research output: Contribution to journalArticle

Anticancer Research (2012) 30, 11 (4633)

Cecere, S. C., Cannella, L., Rossetti, S., Di Napoli, M., Pisano, C., Fiore, F., Striano, S., Marra, L., Pignata, S. & Facchini, G., Aug 2012, In : Anticancer Research. 32, 8, p. 3592 1 p.

Research output: Contribution to journalArticle

CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: Experience of the GCIG CALYPSO trial

Alexandre, J., Brown, C., Coeffic, D., Raban, N., Pfisterer, J., Mäenpää, J., Chalchal, H., Fitzharris, B., Volgger, B., Vergote, I., Pisano, C., Ferrero, A. & Pujade-Lauraine, E., Feb 14 2012, In : British Journal of Cancer. 106, 4, p. 633-637 5 p.

Research output: Contribution to journalArticle

2011

A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy

Pignata, S., Amant, F., Scambia, G., Sorio, R., Breda, E., Rasch, W., Hernes, K., Pisano, C., Leunen, K., Lorusso, D., Cannella, L. & Vergote, I., Nov 2011, In : Cancer Chemotherapy and Pharmacology. 68, 5, p. 1347-1353 7 p.

Research output: Contribution to journalArticle

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial

Pignata, S., Scambia, G., Ferrandina, G., Savarese, A., Sorio, R., Breda, E., Gebbia, V., Musso, P., Frigerio, L., Del Medico, P., Lombardi, A. V., Febbraro, A., Scollo, P., Ferro, A., Tamberi, S., Brandes, A., Ravaioli, A., Valerio, M. R., Aitini, E., Natale, D. & 10 others, Scaltriti, L., Greggi, S., Pisano, C., Lorusso, D., Salutari, V., Legge, F., Di Maio, M., Morabito, A., Gallo, C. & Perrone, F., Sep 20 2011, In : Journal of Clinical Oncology. 29, 27, p. 3628-3635 8 p.

Research output: Contribution to journalArticle

Chemotherapy in epithelial ovarian cancer

Pignata, S., Cannella, L., Leopardo, D., Pisano, C., Bruni, G. S. & Facchini, G., Apr 28 2011, In : Cancer Letters. 303, 2, p. 73-83 11 p.

Research output: Contribution to journalArticle

Follow-up with CA125 after primary therapy of advanced ovarian cancer: In favor of continuing to prescribe CA125 during follow-up

Pignata, S., Cannella, L., Leopardo, D., Bruni, G. S., Facchini, G. & Pisano, C., 2011, In : Annals of Oncology. 22, SUPPL.8, p. 40-44 5 p.

Research output: Contribution to journalArticle